These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 4364431

  • 1. [Clinical experience with betain citrate (author's transl)].
    Babucke G, Sarre B.
    Med Klin; 1973 Aug 24; 68(34):1109-13. PubMed ID: 4364431
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of liver diseases, especially of fatty liver with betaine citrate].
    Semmler F.
    Ther Ggw; 1977 Nov 24; 116(11):2113-24. PubMed ID: 337559
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical results using betaine citrate (Flacar) in fatty livers].
    Hilt G, Tuzin P.
    Med Monatsschr; 1973 Jul 24; 27(7):322-5. PubMed ID: 4731683
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW, Haase W.
    Schweiz Rundsch Med Prax; 1975 Sep 09; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract] [Full Text] [Related]

  • 5. [Thiomesterone and liver function].
    Pickert H.
    Med Klin; 1968 Aug 02; 63(31):1222-6. PubMed ID: 5719699
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S, Gonvers JJ, Hofstetter JR.
    Schweiz Rundsch Med Prax; 1975 May 13; 64(19):595-8. PubMed ID: 51497
    [No Abstract] [Full Text] [Related]

  • 7. [Betaine aspartate in the hepato-digestive domain].
    Cachin M, Pergola F.
    Sem Ther; 1966 Oct 13; 42(8):423-4. PubMed ID: 5994378
    [No Abstract] [Full Text] [Related]

  • 8. [Long-term therapy of liver diseases].
    Markoff N.
    Wien Med Wochenschr; 1972 Feb 12; 122(7):95-9. PubMed ID: 4621921
    [No Abstract] [Full Text] [Related]

  • 9. [Liver function studies with 131-I-bromsulphalein (author's transl)].
    Strötges MW, Nehen HG, Heissen E.
    Leber Magen Darm; 1973 Dec 12; 3(6):257-60. PubMed ID: 4785772
    [No Abstract] [Full Text] [Related]

  • 10. [Betaine aspartate in the therapy of liver diseases].
    Cairella M, Volpari B.
    Clin Ter; 1972 Mar 31; 60(6):513-34. PubMed ID: 5038777
    [No Abstract] [Full Text] [Related]

  • 11. [Demonstration of beta-lipoproteins in patients with chronic hepatitis by beta-L test (author's transl)].
    Fassati P, Jezková Z, Fassati M.
    Cas Lek Cesk; 1973 Aug 07; 112(36):1095-8. PubMed ID: 4355896
    [No Abstract] [Full Text] [Related]

  • 12. [Use of "Essenciale" in the treatment of liver diseases].
    Pogromov AP, Ol'binskaia LI, Antonenko NI, Gitel' NP, Smolianitskiĭ AIa.
    Klin Med (Mosk); 1978 Oct 07; 56(10):97-101. PubMed ID: 362064
    [No Abstract] [Full Text] [Related]

  • 13. [Further clinical experiences with ornithine aspartate in liver diseases].
    Wotzka R, Weber D.
    Ther Ggw; 1972 Mar 07; 111(3):400-12. PubMed ID: 5024593
    [No Abstract] [Full Text] [Related]

  • 14. Therapeutic trial with methylphenobarbital (Prominal), an enzyme inducer, in liver disease. A contribution to the question of hepatotoxicity of barbiturates.
    Glogner P, Massarrat S, Henrichs HR.
    Acta Hepatosplenol; 1971 Mar 07; 18(5):394-7. PubMed ID: 5112056
    [No Abstract] [Full Text] [Related]

  • 15. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H, Weber D, Wotzka R.
    Med Klin; 1969 Mar 07; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract] [Full Text] [Related]

  • 16. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].
    Rapino P, Marulli R, Rapex G, Della Lunga S, Sabatino P.
    Minerva Med; 1982 Oct 20; 73(40):2853-60. PubMed ID: 7133498
    [No Abstract] [Full Text] [Related]

  • 17. [Use of ornithine carbamoyltransferase in the treatment of liver diseases].
    Caruso N, De Jacobis M, Roccato M, Sequino A, Sgoifo B, Tinello M.
    Clin Ter; 1984 Jul 15; 110(1):37-44. PubMed ID: 6237844
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical significance of leucine aminopeptidase in serum (author's transl)].
    Miura T, Chiba M, Terasaki S, Ouchi E.
    Rinsho Byori; 1981 Jun 15; 29(6):622-6. PubMed ID: 7339067
    [No Abstract] [Full Text] [Related]

  • 19. [A new biochemical aspect of liver therapy].
    Gäbler H.
    Ther Ggw; 1971 Apr 15; 110(4):505-14. PubMed ID: 5574294
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical experimentation with Aïcamine in hepatic insufficiency].
    Négret JP.
    Bord Med; 1972 Apr 15; 5(8):973-6. PubMed ID: 5053280
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.